nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Timolol—migraine	0.443	1	CrCtD
Bupranolol—ADRB3—Timolol—migraine	0.0734	0.292	CbGbCtD
Bupranolol—ADRB3—Propranolol—migraine	0.0655	0.26	CbGbCtD
Bupranolol—Levobunolol—Timolol—migraine	0.0631	0.233	CrCrCtD
Bupranolol—Penbutolol—Timolol—migraine	0.0574	0.212	CrCrCtD
Bupranolol—Bopindolol—Propranolol—migraine	0.0336	0.124	CrCrCtD
Bupranolol—Levobunolol—Propranolol—migraine	0.0336	0.124	CrCrCtD
Bupranolol—Carteolol—Propranolol—migraine	0.0336	0.124	CrCrCtD
Bupranolol—Penbutolol—Propranolol—migraine	0.0306	0.113	CrCrCtD
Bupranolol—ADRB2—Timolol—migraine	0.03	0.119	CbGbCtD
Bupranolol—ADRB1—Timolol—migraine	0.0296	0.118	CbGbCtD
Bupranolol—ADRB2—Propranolol—migraine	0.0268	0.106	CbGbCtD
Bupranolol—ADRB1—Propranolol—migraine	0.0264	0.105	CbGbCtD
Bupranolol—Pindolol—Propranolol—migraine	0.0184	0.068	CrCrCtD
Bupranolol—Bopindolol—HTR1B—migraine	0.000312	0.178	CrCbGaD
Bupranolol—Penbutolol—HTR1B—migraine	0.000298	0.17	CrCbGaD
Bupranolol—Clenbuterol—TNF—migraine	0.000277	0.158	CrCbGaD
Bupranolol—ADRB2—G alpha (s) signalling events—CALCRL—migraine	0.000261	0.00781	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—HTR2C—migraine	0.000258	0.00774	CbGpPWpGaD
Bupranolol—Bopindolol—HTR1A—migraine	0.000247	0.141	CrCbGaD
Bupranolol—Penbutolol—HTR1A—migraine	0.000236	0.134	CrCbGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.000231	0.00693	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—HTR7—migraine	0.000226	0.00678	CbGpPWpGaD
Bupranolol—Pindolol—HTR1B—migraine	0.000215	0.122	CrCbGaD
Bupranolol—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000193	0.00578	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—HTR2A—migraine	0.000189	0.00565	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—NPS—migraine	0.000187	0.00561	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000181	0.00544	CbGpPWpGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000174	0.00522	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—CALCA—migraine	0.000172	0.00515	CbGpPWpGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.00017	0.00511	CbGpPWpGaD
Bupranolol—Pindolol—HTR1A—migraine	0.00017	0.0969	CrCbGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000169	0.00505	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—RAMP1—migraine	0.000163	0.00488	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CALCRL—migraine	0.000163	0.00488	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000162	0.00486	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—HTR7—migraine	0.000161	0.00482	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.000159	0.00475	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000155	0.00466	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000144	0.00433	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—EDNRA—migraine	0.000133	0.00398	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—HTR7—migraine	0.00012	0.00358	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR1D—migraine	0.000118	0.00355	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—NPS—migraine	0.000111	0.00333	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR2B—migraine	0.00011	0.0033	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00011	0.00329	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—NPS—migraine	0.000109	0.00326	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000108	0.00323	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000106	0.00317	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000105	0.00316	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000102	0.00306	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—CALCA—migraine	0.000102	0.00306	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.0001	0.003	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—CALCA—migraine	9.98e-05	0.00299	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	9.94e-05	0.00298	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	9.79e-05	0.00293	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CALCRL—migraine	9.67e-05	0.0029	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—RAMP1—migraine	9.67e-05	0.0029	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—HTR7—migraine	9.55e-05	0.00286	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CALCRL—migraine	9.46e-05	0.00283	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—RAMP1—migraine	9.46e-05	0.00283	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	9.42e-05	0.00282	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—HTR7—migraine	9.34e-05	0.0028	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	9.23e-05	0.00276	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CALCRL—migraine	9.21e-05	0.00276	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—RAMP1—migraine	9.21e-05	0.00276	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	9.06e-05	0.00272	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	9.02e-05	0.0027	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR7—migraine	8.95e-05	0.00268	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	8.93e-05	0.00267	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	8.93e-05	0.00267	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	8.75e-05	0.00262	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	8.58e-05	0.00257	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	8.52e-05	0.00255	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	8.39e-05	0.00251	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—HTR2A—migraine	8.38e-05	0.00251	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—RAMP1—migraine	8.36e-05	0.0025	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CALCRL—migraine	8.36e-05	0.0025	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	7.67e-05	0.0023	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR1B—migraine	7.17e-05	0.00215	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR1D—migraine	7.02e-05	0.0021	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR1A—migraine	6.9e-05	0.00207	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR1D—migraine	6.87e-05	0.00206	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—NPS—migraine	6.8e-05	0.00204	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—TAC1—migraine	6.8e-05	0.00204	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR1D—migraine	6.69e-05	0.002	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR2C—migraine	6.67e-05	0.002	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR2B—migraine	6.53e-05	0.00196	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	6.52e-05	0.00195	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—EDNRA—migraine	6.48e-05	0.00194	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR2B—migraine	6.39e-05	0.00191	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	6.38e-05	0.00191	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	6.28e-05	0.00188	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	6.27e-05	0.00188	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CALCA—migraine	6.24e-05	0.00187	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR2B—migraine	6.22e-05	0.00186	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	6.14e-05	0.00184	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR1D—migraine	6.07e-05	0.00182	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	6.06e-05	0.00182	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	5.93e-05	0.00178	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	5.9e-05	0.00177	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR7—migraine	5.84e-05	0.00175	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	5.77e-05	0.00173	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR2B—migraine	5.65e-05	0.00169	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	5.59e-05	0.00167	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	5.47e-05	0.00164	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CALCRL—migraine	5.46e-05	0.00164	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—RAMP1—migraine	5.46e-05	0.00164	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.38e-05	0.00161	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.37e-05	0.00161	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CALCRL—migraine	5.34e-05	0.0016	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—RAMP1—migraine	5.34e-05	0.0016	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.31e-05	0.00159	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.3e-05	0.00159	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.3e-05	0.00159	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.26e-05	0.00158	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.2e-05	0.00156	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	5.2e-05	0.00156	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.18e-05	0.00155	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.18e-05	0.00155	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	5.08e-05	0.00152	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	5.05e-05	0.00151	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CALCRL—migraine	4.96e-05	0.00149	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—RAMP1—migraine	4.96e-05	0.00149	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	4.94e-05	0.00148	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CALCRL—migraine	4.94e-05	0.00148	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RAMP1—migraine	4.94e-05	0.00148	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—RAMP1—migraine	4.85e-05	0.00145	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CALCRL—migraine	4.85e-05	0.00145	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.55e-05	0.00136	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.45e-05	0.00133	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR1B—migraine	4.26e-05	0.00128	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR1B—migraine	4.16e-05	0.00125	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR1A—migraine	4.1e-05	0.00123	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR2A—migraine	4.09e-05	0.00123	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR1B—migraine	4.05e-05	0.00121	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—TAC1—migraine	4.03e-05	0.00121	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—NPS—migraine	4.03e-05	0.00121	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR1A—migraine	4.01e-05	0.0012	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR1D—migraine	3.97e-05	0.00119	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR2C—migraine	3.96e-05	0.00119	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—NPS—migraine	3.95e-05	0.00118	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—TAC1—migraine	3.95e-05	0.00118	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR1A—migraine	3.9e-05	0.00117	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR1D—migraine	3.88e-05	0.00116	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR2C—migraine	3.87e-05	0.00116	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—EDNRA—migraine	3.85e-05	0.00115	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—NPS—migraine	3.84e-05	0.00115	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—TAC1—migraine	3.84e-05	0.00115	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR2C—migraine	3.77e-05	0.00113	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—EDNRA—migraine	3.77e-05	0.00113	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.72e-05	0.00111	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CALCA—migraine	3.71e-05	0.00111	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR2B—migraine	3.69e-05	0.00111	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR1B—migraine	3.68e-05	0.0011	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—EDNRA—migraine	3.66e-05	0.0011	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.64e-05	0.00109	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CALCA—migraine	3.62e-05	0.00109	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR2B—migraine	3.61e-05	0.00108	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR1D—migraine	3.61e-05	0.00108	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR1D—migraine	3.59e-05	0.00108	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR1A—migraine	3.54e-05	0.00106	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CALCA—migraine	3.53e-05	0.00106	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR1D—migraine	3.53e-05	0.00106	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—NPS—migraine	3.49e-05	0.00105	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TAC1—migraine	3.49e-05	0.00105	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR7—migraine	3.47e-05	0.00104	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR2C—migraine	3.42e-05	0.00103	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR7—migraine	3.39e-05	0.00102	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2B—migraine	3.35e-05	0.001	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2B—migraine	3.34e-05	0.000999	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—EDNRA—migraine	3.33e-05	0.000997	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR7—migraine	3.3e-05	0.000989	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2B—migraine	3.28e-05	0.000982	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CALCA—migraine	3.2e-05	0.00096	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.19e-05	0.000955	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.12e-05	0.000934	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR7—migraine	3e-05	0.000898	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—LRP1—migraine	2.94e-05	0.00088	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RAMP1—migraine	2.93e-05	0.000878	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CALCRL—migraine	2.93e-05	0.000878	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RAMP1—migraine	2.87e-05	0.000859	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CALCRL—migraine	2.87e-05	0.000859	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR2A—migraine	2.43e-05	0.000727	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR1B—migraine	2.41e-05	0.000721	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR2A—migraine	2.37e-05	0.000711	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR1B—migraine	2.35e-05	0.000705	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR1A—migraine	2.32e-05	0.000694	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR2A—migraine	2.31e-05	0.000692	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—TAC1—migraine	2.28e-05	0.000683	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—NPS—migraine	2.28e-05	0.000683	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR1A—migraine	2.26e-05	0.000679	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NOTCH4—migraine	2.25e-05	0.000675	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR2C—migraine	2.24e-05	0.00067	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—NPS—migraine	2.23e-05	0.000668	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—TAC1—migraine	2.23e-05	0.000668	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR2C—migraine	2.19e-05	0.000655	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR1B—migraine	2.18e-05	0.000654	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—EDNRA—migraine	2.18e-05	0.000652	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR1B—migraine	2.17e-05	0.000651	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR1B—migraine	2.14e-05	0.00064	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR1D—migraine	2.13e-05	0.000638	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—EDNRA—migraine	2.13e-05	0.000638	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR1A—migraine	2.1e-05	0.00063	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR2A—migraine	2.1e-05	0.000629	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CALCA—migraine	2.09e-05	0.000627	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR1A—migraine	2.09e-05	0.000627	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR1D—migraine	2.08e-05	0.000624	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TAC1—migraine	2.07e-05	0.00062	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—NPS—migraine	2.07e-05	0.00062	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NPS—migraine	2.06e-05	0.000617	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TAC1—migraine	2.06e-05	0.000617	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PGR—migraine	2.06e-05	0.000617	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR1A—migraine	2.06e-05	0.000616	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CALCA—migraine	2.05e-05	0.000614	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2C—migraine	2.03e-05	0.000608	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—NPS—migraine	2.03e-05	0.000607	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TAC1—migraine	2.03e-05	0.000607	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2C—migraine	2.02e-05	0.000606	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2C—migraine	1.99e-05	0.000595	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2B—migraine	1.98e-05	0.000593	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EDNRA—migraine	1.98e-05	0.000592	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EDNRA—migraine	1.97e-05	0.000589	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR7—migraine	1.96e-05	0.000587	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2B—migraine	1.94e-05	0.00058	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EDNRA—migraine	1.93e-05	0.000579	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NOTCH3—migraine	1.92e-05	0.000574	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR7—migraine	1.92e-05	0.000574	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CALCA—migraine	1.9e-05	0.00057	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CALCA—migraine	1.89e-05	0.000567	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CALCA—migraine	1.86e-05	0.000557	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR7—migraine	1.78e-05	0.000533	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR7—migraine	1.77e-05	0.00053	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LRP1—migraine	1.74e-05	0.000522	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR7—migraine	1.74e-05	0.000521	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LRP1—migraine	1.71e-05	0.000511	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TGFBR2—migraine	1.52e-05	0.000457	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR2A—migraine	1.37e-05	0.000411	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR2A—migraine	1.34e-05	0.000402	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOTCH4—migraine	1.34e-05	0.000401	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOTCH4—migraine	1.31e-05	0.000392	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR1B—migraine	1.29e-05	0.000387	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR1B—migraine	1.26e-05	0.000378	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2A—migraine	1.25e-05	0.000373	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR1A—migraine	1.24e-05	0.000372	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2A—migraine	1.24e-05	0.000371	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PGR—migraine	1.22e-05	0.000366	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NPS—migraine	1.22e-05	0.000366	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TAC1—migraine	1.22e-05	0.000366	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2A—migraine	1.22e-05	0.000365	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR1A—migraine	1.21e-05	0.000364	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2C—migraine	1.2e-05	0.000359	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TAC1—migraine	1.2e-05	0.000358	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NPS—migraine	1.2e-05	0.000358	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PGR—migraine	1.2e-05	0.000358	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2C—migraine	1.17e-05	0.000352	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDNRA—migraine	1.17e-05	0.00035	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDNRA—migraine	1.14e-05	0.000342	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOTCH3—migraine	1.14e-05	0.000341	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CALCA—migraine	1.12e-05	0.000337	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOTCH3—migraine	1.11e-05	0.000333	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ESR1—migraine	1.1e-05	0.00033	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CALCA—migraine	1.1e-05	0.000329	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR7—migraine	1.05e-05	0.000315	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR7—migraine	1.03e-05	0.000308	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TGFBR2—migraine	9.05e-06	0.000271	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TGFBR2—migraine	8.85e-06	0.000265	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2A—migraine	7.36e-06	0.00022	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2A—migraine	7.2e-06	0.000216	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ESR1—migraine	6.53e-06	0.000196	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ESR1—migraine	6.39e-06	0.000191	CbGpPWpGaD
